Australian Broker Call

Produced and copyrighted by at www.fnarena.com

December 02, 2020

Access Broker Call Report Archives here

COMPANIES DISCUSSED IN THIS ISSUE

Click on symbol for fast access.

The number next to the symbol represents the number of brokers covering it for this report -(if more than 1).

Last Updated: 05:00 PM

Your daily news report on the latest recommendation, valuation, forecast and opinion changes.

This report includes concise but limited reviews of research recently published by Stockbrokers, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end.

For more info about the different terms used by stockbrokers, as well as the different methodologies behind similar sounding ratings, download our guide HERE

Today's Upgrades and Downgrades
DMP - Domino's Pizza Upgrade to Add from Hold Morgans
Upgrade to Neutral from Sell UBS
HLO - HELLOWORLD TRAVEL Downgrade to Lighten from Buy Ord Minnett
IGO - IGO Co Upgrade to Lighten from Sell Ord Minnett
SFR - Sandfire Upgrade to Outperform from Neutral Macquarie
STO - Santos Downgrade to Neutral from Outperform Credit Suisse
WEB - Webjet Downgrade to Hold from Buy Ord Minnett
ABY  ADORE BEAUTY GROUP LIMITED

Household & Personal Products

More Research Tools In Stock Analysis - click HERE

Overnight Price: $6.33

Morgan Stanley rates ABY as Overweight (1) -

The company has upgraded first half revenue forecasts to $95.2m, which Morgan Stanley understands implies 83% growth. Strong growth is attributed to the better performance over November.

The broker awaits further clarity on the gross margin impacts but believes it is sensible to prioritise growth, given the migration online for beauty products is in its infancy.

Overweight rating. Target is $8.35. Industry view: In-line.  

Target price is $8.35 Current Price is $6.33 Difference: $2.02
If ABY meets the Morgan Stanley target it will return approximately 32% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 dividend of 0.00 cents and EPS of 5.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 126.60.

Forecast for FY22:

Morgan Stanley forecasts a full year FY22 dividend of 0.00 cents and EPS of 8.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 79.13.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

AUB  AUB GROUP LIMITED

Diversified Financials

More Research Tools In Stock Analysis - click HERE

Overnight Price: $16.67

Macquarie rates AUB as Outperform (1) -

AUB Group will own circa 54% of the new general commercial underwriting subdivision (GCU), a part of the restructured AUB underwriting agencies division post the 360 Underwriting Solutions acquisition.

Macquarie notes 360 Underwriting Solutions is one of the few key independent underwriting agency groups left and its acquisition adds scale to AUB Group's agency offering.

The group's restructured underwriting agency division will comprise 3 subdivisions - general commercial underwriting, SURA Specialty and Strata Agencies,

Macquarie retains its Outperform rating and raises the target to $18.57 from $17.53.

Target price is $18.57 Current Price is $16.67 Difference: $1.9
If AUB meets the Macquarie target it will return approximately 11% (excluding dividends, fees and charges).

Current consensus price target is $18.94, suggesting upside of 10.9% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 53.00 cents and EPS of 83.60 cents.
At the last closing share price the estimated dividend yield is 3.18%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.94.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 79.9, implying annual growth of 24.6%.

Current consensus DPS estimate is 53.3, implying a prospective dividend yield of 3.1%.

Current consensus EPS estimate suggests the PER is 21.4.

Forecast for FY22:

Macquarie forecasts a full year FY22 dividend of 53.00 cents and EPS of 88.40 cents.
At the last closing share price the estimated dividend yield is 3.18%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.86.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 83.8, implying annual growth of 4.9%.

Current consensus DPS estimate is 54.7, implying a prospective dividend yield of 3.2%.

Current consensus EPS estimate suggests the PER is 20.4.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CKF  COLLINS FOODS LIMITED

Food, Beverages & Tobacco

More Research Tools In Stock Analysis - click HERE

Overnight Price: $10.37

Morgans rates CKF as Add (1) -

Collins Foods first half result demonstrated to Morgans the strength of the KFC Australia business. This more than offset the performances of Sizzler, Taco Bell and KFC Europe, which were slightly below the broker’s expectations.

Key highlights for the analyst included a rise in group revenue by 11.3%, an increase in earnings (EBITDA) of 10.5% and a profit (NPAT) increase of 15.1%.

Morgans thinks KFC Australia earnings can incrementally grow into FY22, while Sizzler and Taco Bell profitability should improve.

The Add rating is maintained and the target increased to $11.39 from $10.80.

Target price is $11.39 Current Price is $10.37 Difference: $1.02
If CKF meets the Morgans target it will return approximately 10% (excluding dividends, fees and charges).

The company's fiscal year ends in May.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 23.00 cents and EPS of 42.00 cents.
At the last closing share price the estimated dividend yield is 2.22%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 24.69.

Forecast for FY22:

Morgans forecasts a full year FY22 dividend of 26.00 cents and EPS of 52.00 cents.
At the last closing share price the estimated dividend yield is 2.51%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.94.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


UBS rates CKF as Buy (1) -

Collins Foods first half result shows operating income beat UBS's forecast by 11%. KFC Australia's like for like sales were 12.4% versus the broker's estimated 5.4%.

UBS believes the business continues to be driven by multiple tailwinds including a continued uptake in delivery, rising market share via drive-through and continued store rollouts.

The broker retains its Buy rating. Target is raised to $11.65 from $10.65.

Target price is $11.65 Current Price is $10.37 Difference: $1.28
If CKF meets the UBS target it will return approximately 12% (excluding dividends, fees and charges).

The company's fiscal year ends in May.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 22.00 cents and EPS of 37.00 cents.
At the last closing share price the estimated dividend yield is 2.12%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 28.03.

Forecast for FY22:

UBS forecasts a full year FY22 dividend of 25.60 cents and EPS of 43.10 cents.
At the last closing share price the estimated dividend yield is 2.47%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 24.06.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CSL  CSL LIMITED

Pharmaceuticals & Biotech/Lifesciences

More Research Tools In Stock Analysis - click HERE

Overnight Price: $299.75

Macquarie rates CSL as Neutral (3) -

Macquarie notes CSL's Haegarda has delivered strong revenue growth since launch but Japanese rival Takeda's Takhzyro has also seen its share increase recently.

While delivering strong revenue growth since its launch in 2017, the broker sees many factors that can impact Haegarda's revenue from FY22. Latest results from Garadacimab look promising but the launch is expected post-2023. 

Neutral rating. Target is $296.

Target price is $296.00 Current Price is $299.75 Difference: minus $3.75 (current price is over target).
If CSL meets the Macquarie target it will return approximately minus 1% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $316.81, suggesting upside of 6.8% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 336.30 cents and EPS of 744.42 cents.
At the last closing share price the estimated dividend yield is 1.12%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 40.27.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 673.9, implying annual growth of N/A.

Current consensus DPS estimate is 298.1, implying a prospective dividend yield of 1.0%.

Current consensus EPS estimate suggests the PER is 44.0.

Forecast for FY22:

Macquarie forecasts a full year FY22 dividend of 376.15 cents and EPS of 833.02 cents.
At the last closing share price the estimated dividend yield is 1.25%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 35.98.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 745.7, implying annual growth of 10.7%.

Current consensus DPS estimate is 337.1, implying a prospective dividend yield of 1.1%.

Current consensus EPS estimate suggests the PER is 39.8.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Morgan Stanley rates CSL as Equal-weight (3) -

Morgan Stanley considers FY22 plasma profits will be challenged and while this may be offset by V451 (covid-19 vaccine candidate)  success/demand and the magnitude of profit remains unclear.

The first phase 2b/3 patient is expected to be dosed in December with recruitment completed by March 2021. Based on competitor timeframes this could translate to a broad vaccine being available during the first half of FY22.

While CSL has prior experience in pandemic response with H1N1 Morgan Stanley does not include V451 in its base case estimates because of the uncertainty.

Equal-weight rating and $294 price target. Industry view: In-line.

Target price is $294.00 Current Price is $299.75 Difference: minus $5.75 (current price is over target).
If CSL meets the Morgan Stanley target it will return approximately minus 2% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $316.81, suggesting upside of 6.8% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 EPS of 719.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 41.65.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 673.9, implying annual growth of N/A.

Current consensus DPS estimate is 298.1, implying a prospective dividend yield of 1.0%.

Current consensus EPS estimate suggests the PER is 44.0.

Forecast for FY22:

Morgan Stanley forecasts a full year FY22 EPS of 722.52 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 41.49.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 745.7, implying annual growth of 10.7%.

Current consensus DPS estimate is 337.1, implying a prospective dividend yield of 1.1%.

Current consensus EPS estimate suggests the PER is 39.8.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.4

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

DMP  DOMINO'S PIZZA ENTERPRISES LIMITED

Food, Beverages & Tobacco

More Research Tools In Stock Analysis - click HERE

Overnight Price: $83.17

Morgans rates DMP as Upgrade to Add from Hold (1) -

Following recent share price falls and positive momentum across the company, Morgans upgrades the rating to Add from Hold.

It was clear to Morgans after an investor briefing that Japan and Germany are exhibiting strong top-line growth and margin expansion. 

The broker highlights management comments that Germany would likely become the company’s strongest growth market for the short-term and ultimately become the largest market.

The target price is increased to $82.96 from $81.29.

Target price is $82.96 Current Price is $83.17 Difference: minus $0.21 (current price is over target).
If DMP meets the Morgans target it will return approximately minus 0% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $72.60, suggesting downside of -11.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 140.00 cents and EPS of 199.00 cents.
At the last closing share price the estimated dividend yield is 1.68%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 41.79.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 201.8, implying annual growth of 25.4%.

Current consensus DPS estimate is 142.4, implying a prospective dividend yield of 1.7%.

Current consensus EPS estimate suggests the PER is 40.7.

Forecast for FY22:

Morgans forecasts a full year FY22 dividend of 159.00 cents and EPS of 227.00 cents.
At the last closing share price the estimated dividend yield is 1.91%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 36.64.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 224.8, implying annual growth of 11.4%.

Current consensus DPS estimate is 158.2, implying a prospective dividend yield of 1.9%.

Current consensus EPS estimate suggests the PER is 36.5.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


UBS rates DMP as Upgrade to Neutral from Sell (3) -

UBS upgrades its rating on Domino's Pizza Enterprises to Neutral from Sell.

UBS found the company's 2020 investor day to be positive with takeaways operating leverage expected to improve and most of the second half covid costs unlikely to repeat in FY21.

Also, the broker highlights strong franchisee profit across the board with Germany scaling up and Japan expected to continue to grow.

Target is unchanged at $72.

Target price is $72.00 Current Price is $83.17 Difference: minus $11.17 (current price is over target).
If DMP meets the UBS target it will return approximately minus 13% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $72.60, suggesting downside of -11.6% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 141.40 cents and EPS of 200.70 cents.
At the last closing share price the estimated dividend yield is 1.70%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 41.44.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 201.8, implying annual growth of 25.4%.

Current consensus DPS estimate is 142.4, implying a prospective dividend yield of 1.7%.

Current consensus EPS estimate suggests the PER is 40.7.

Forecast for FY22:

UBS forecasts a full year FY22 dividend of 161.10 cents and EPS of 229.30 cents.
At the last closing share price the estimated dividend yield is 1.94%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 36.27.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 224.8, implying annual growth of 11.4%.

Current consensus DPS estimate is 158.2, implying a prospective dividend yield of 1.9%.

Current consensus EPS estimate suggests the PER is 36.5.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

FBU  FLETCHER BUILDING LIMITED

Building Products & Services

More Research Tools In Stock Analysis - click HERE

Overnight Price: $5.48

UBS rates FBU as Neutral (3) -

UBS observes Fletcher Building's share price is now sitting in line with pre-covid-19 levels, post some significant earnings upgrades with construction activity in New Zealand noting a rebound post-lockdown along with cost-saving initiatives by the company.

The broker expects construction spend in New Zealand to lift by 12% in 2021-22 with stronger residential and infrastructure activity countered by lower non-residential work. Infrastructure expenditure on projects over $100m is expected to increase by 8% by 2022.

The broker believes Fletcher Building will restart its dividend of 15c in FY21.

Neutral rating is under review with the target rising to NZ$6 from NZ$3.50.

Current Price is $5.48. Target price not assessed.

Current consensus price target is N/A

The company's fiscal year ends in June.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 14.15 cents and EPS of 35.09 cents.
At the last closing share price the estimated dividend yield is 2.58%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.62.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 35.7, implying annual growth of N/A.

Current consensus DPS estimate is 16.5, implying a prospective dividend yield of 3.0%.

Current consensus EPS estimate suggests the PER is 15.4.

Forecast for FY22:

UBS forecasts a full year FY22 dividend of 18.87 cents and EPS of 40.19 cents.
At the last closing share price the estimated dividend yield is 3.44%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.64.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 35.8, implying annual growth of 0.3%.

Current consensus DPS estimate is 21.5, implying a prospective dividend yield of 3.9%.

Current consensus EPS estimate suggests the PER is 15.4.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.2

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

GNC  GRAINCORP LIMITED

Agriculture

More Research Tools In Stock Analysis - click HERE

Overnight Price: $4.45

Macquarie rates GNC as Outperform (1) -

ABARES's third East Coast Australia (ECA) crop production pegs winter crop for 2020-21 at 28.6mmt, up 19% versus the second estimate of 24.4mt.

GrainCrop, not seeing any China-related impacts with counterparties and noting good demand for Australian grain, expects the 2020-21 winter crop to be of similar size to FY17. Also, the broker expects a large exportable surplus with higher margins.

FY22 earnings are expected to be supported by a grain carry-in benefit and a solid outlook for the processing business.

Macquarie retains its Outperform rating with the target rising to $5.35 from $5.26.

Target price is $5.35 Current Price is $4.45 Difference: $0.9
If GNC meets the Macquarie target it will return approximately 20% (excluding dividends, fees and charges).

Current consensus price target is $5.08, suggesting upside of 11.6% (ex-dividends)

The company's fiscal year ends in September.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 13.80 cents and EPS of 23.40 cents.
At the last closing share price the estimated dividend yield is 3.10%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.02.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 26.2, implying annual growth of -82.5%.

Current consensus DPS estimate is 15.3, implying a prospective dividend yield of 3.4%.

Current consensus EPS estimate suggests the PER is 17.4.

Forecast for FY22:

Macquarie forecasts a full year FY22 dividend of 14.10 cents and EPS of 24.00 cents.
At the last closing share price the estimated dividend yield is 3.17%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.54.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 27.1, implying annual growth of 3.4%.

Current consensus DPS estimate is 15.7, implying a prospective dividend yield of 3.5%.

Current consensus EPS estimate suggests the PER is 16.8.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


UBS rates GNC as Buy (1) -

ABARES has upgraded its Australian east-coast winter crop outlook to 28.6mt from 24.4mt, above UBS's forecast of circa 27mt. This is also consistent with GrainCorp's commentary expecting a crop similar to FY17 levels at about 28mt.

UBS believes there may be potential for a further upgrade at ABARES' next quarterly update in February to more than 30mt.

The broker prices in a 28.6mt crop that leads to FY21 operating income forecast lifting by 10%. Also, the broker highlights a strong crop in FY21 would also support earnings in FY22.

Target rises to $5.15 from $4.90, Buy retained.

Target price is $5.15 Current Price is $4.45 Difference: $0.7
If GNC meets the UBS target it will return approximately 16% (excluding dividends, fees and charges).

Current consensus price target is $5.08, suggesting upside of 11.6% (ex-dividends)

The company's fiscal year ends in September.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 17.20 cents and EPS of 28.70 cents.
At the last closing share price the estimated dividend yield is 3.87%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.51.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 26.2, implying annual growth of -82.5%.

Current consensus DPS estimate is 15.3, implying a prospective dividend yield of 3.4%.

Current consensus EPS estimate suggests the PER is 17.4.

Forecast for FY22:

UBS forecasts a full year FY22 dividend of 18.20 cents and EPS of 30.40 cents.
At the last closing share price the estimated dividend yield is 4.09%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.64.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 27.1, implying annual growth of 3.4%.

Current consensus DPS estimate is 15.7, implying a prospective dividend yield of 3.5%.

Current consensus EPS estimate suggests the PER is 16.8.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

GPT  GPT GROUP

Infra & Property Developers

More Research Tools In Stock Analysis - click HERE

Overnight Price: $4.67

Macquarie rates GPT as Neutral (3) -

GPT Group divested a 25% stake in 1 Farrer Place and acquired three logistics assets. 

While Macquarie believes divesting office assets and reinvesting into logistics is likely to be accretive to free cashflow, the risk profile is different in logistics given the development risk and leasing risk at expiry for assets acquired at tight yields.

Neutral rating is retained with a target of $4.79.

Target price is $4.79 Current Price is $4.67 Difference: $0.12
If GPT meets the Macquarie target it will return approximately 3% (excluding dividends, fees and charges).

Current consensus price target is $4.54, suggesting downside of -3.0% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 18.10 cents and EPS of 22.60 cents.
At the last closing share price the estimated dividend yield is 3.88%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.66.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 25.9, implying annual growth of -42.8%.

Current consensus DPS estimate is 19.1, implying a prospective dividend yield of 4.1%.

Current consensus EPS estimate suggests the PER is 18.1.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 23.80 cents and EPS of 28.50 cents.
At the last closing share price the estimated dividend yield is 5.10%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.39.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 30.6, implying annual growth of 18.1%.

Current consensus DPS estimate is 23.7, implying a prospective dividend yield of 5.1%.

Current consensus EPS estimate suggests the PER is 15.3.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Morgan Stanley rates GPT as Underweight (5) -

GPT has sold its 25% stake in One Farrer Place for $584.6m, in line with book value. Morgan Stanley assesses the transaction is mildly dilutive but the ultimate impact will depend on how fast GPT can reinvest the proceeds.

Gearing will drop to around 22% on a pro forma basis, making the company one of the more conservative names under the broker's coverage.

Morgan Stanley does speculate whether listed landlords are preparing for a tough period of leasing in the next 12-18 months.

Underweight rating with a target of $4.00. Industry view is In-Line.

Target price is $4.00 Current Price is $4.67 Difference: minus $0.67 (current price is over target).
If GPT meets the Morgan Stanley target it will return approximately minus 14% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $4.54, suggesting downside of -3.0% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

Morgan Stanley forecasts a full year FY20 dividend of 18.30 cents and EPS of 25.30 cents.
At the last closing share price the estimated dividend yield is 3.92%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.46.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 25.9, implying annual growth of -42.8%.

Current consensus DPS estimate is 19.1, implying a prospective dividend yield of 4.1%.

Current consensus EPS estimate suggests the PER is 18.1.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 dividend of 22.20 cents and EPS of 30.60 cents.
At the last closing share price the estimated dividend yield is 4.75%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.26.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 30.6, implying annual growth of 18.1%.

Current consensus DPS estimate is 23.7, implying a prospective dividend yield of 5.1%.

Current consensus EPS estimate suggests the PER is 15.3.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

HLO  HELLOWORLD TRAVEL LIMITED

Travel, Leisure & Tourism

More Research Tools In Stock Analysis - click HERE

Overnight Price: $3.00

Ord Minnett rates HLO as Downgrade to Lighten from Buy (4) -

Ord Minnett finds valuation stretched in the travel & tourism sector as stocks have rallied on the back of progress with the coronavirus vaccines and domestic border re-opening.

Nevertheless, the broker suspects a meaningful recovery is at least 12-18 months away.

In such circumstances the focus needs to be on stocks that have strong fundamentals while investors need to be nimble and watch for anomalies in valuation at any point in time, in Ord Minnett's view.

Helloworld Travel's rating is downgraded to Lighten from Buy and the target raised to $2.65 from $2.13.

Target price is $2.65 Current Price is $3.00 Difference: minus $0.35 (current price is over target).
If HLO meets the Ord Minnett target it will return approximately minus 12% (excluding dividends, fees and charges - negative figures indicate an expected loss).

The company's fiscal year ends in June.

Forecast for FY21:

Ord Minnett forecasts a full year FY21 dividend of 0.00 cents and EPS of minus 11.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 26.32.

Forecast for FY22:

Ord Minnett forecasts a full year FY22 dividend of 1.30 cents and EPS of 4.80 cents.
At the last closing share price the estimated dividend yield is 0.43%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 62.50.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

IFL  IOOF HOLDINGS LIMITED

Wealth Management & Investments

More Research Tools In Stock Analysis - click HERE

Overnight Price: $3.88

Citi rates IFL as No Rating (-1) -

IOOF has outlined a clear strategy, in Citi's view, although it will be tough to execute.

The underpinnings of the strategy include lower cost platforms that have an economically viable business model in advice and which also expand the target market.

Furthermore, the MLC transaction should provide further scale to build on the strategy.

Citi is unable to provide a rating and target at present.

Current Price is $3.88. Target price not assessed.

Current consensus price target is $4.58, suggesting upside of 19.8% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

Citi forecasts a full year FY21 dividend of 32.00 cents and EPS of 41.40 cents.
At the last closing share price the estimated dividend yield is 8.25%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.37.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 30.2, implying annual growth of -28.1%.

Current consensus DPS estimate is 22.6, implying a prospective dividend yield of 5.9%.

Current consensus EPS estimate suggests the PER is 12.6.

Forecast for FY22:

Current consensus EPS estimate is 31.3, implying annual growth of 3.6%.

Current consensus DPS estimate is 24.0, implying a prospective dividend yield of 6.3%.

Current consensus EPS estimate suggests the PER is 12.2.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Credit Suisse rates IFL as Outperform (1) -

IOOF expects to generate earnings margins from salaried advisers of around 30% and to break even by FY22 for self-employed advisers. Further upside is envisaged should scale eventuate through adviser acquisition.

Credit Suisse also envisages opportunity to monetise more effectively the 1m non-advised clients. To these ends the company is investing in technology. Outperform rating and $5 target retained.

Target price is $5.00 Current Price is $3.88 Difference: $1.12
If IFL meets the Credit Suisse target it will return approximately 29% (excluding dividends, fees and charges).

Current consensus price target is $4.58, suggesting upside of 19.8% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

Credit Suisse forecasts a full year FY21 dividend of 15.00 cents and EPS of 25.00 cents.
At the last closing share price the estimated dividend yield is 3.87%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.52.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 30.2, implying annual growth of -28.1%.

Current consensus DPS estimate is 22.6, implying a prospective dividend yield of 5.9%.

Current consensus EPS estimate suggests the PER is 12.6.

Forecast for FY22:

Credit Suisse forecasts a full year FY22 dividend of 23.00 cents and EPS of 38.00 cents.
At the last closing share price the estimated dividend yield is 5.93%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.21.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 31.3, implying annual growth of 3.6%.

Current consensus DPS estimate is 24.0, implying a prospective dividend yield of 6.3%.

Current consensus EPS estimate suggests the PER is 12.2.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Ord Minnett rates IFL as Buy (1) -

IOOF Holdings expects growth will now be driven by efficiencies in platforms and planning. The company is pushing for more affordable access to advice and the re-setting of fees by Australian financial services licence holders.

Ord Minnett notes no new financial targets were outlined, although the company appears to be intent on making self-employed adviser dealer groups move to break even by FY21 or FY22, from cost reductions and fee increases.

While there was little discussion about revenue margin trends, the broker suspects most of the heavy lifting has already been done. Buy rating and $4.15 target retained.

Target price is $4.15 Current Price is $3.88 Difference: $0.27
If IFL meets the Ord Minnett target it will return approximately 7% (excluding dividends, fees and charges).

Current consensus price target is $4.58, suggesting upside of 19.8% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

Ord Minnett forecasts a full year FY21 dividend of 15.00 cents and EPS of 24.00 cents.
At the last closing share price the estimated dividend yield is 3.87%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.17.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 30.2, implying annual growth of -28.1%.

Current consensus DPS estimate is 22.6, implying a prospective dividend yield of 5.9%.

Current consensus EPS estimate suggests the PER is 12.6.

Forecast for FY22:

Ord Minnett forecasts a full year FY22 dividend of 19.00 cents and EPS of 24.00 cents.
At the last closing share price the estimated dividend yield is 4.90%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.17.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 31.3, implying annual growth of 3.6%.

Current consensus DPS estimate is 24.0, implying a prospective dividend yield of 6.3%.

Current consensus EPS estimate suggests the PER is 12.2.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

IGO  IGO LIMITED

Nickel

More Research Tools In Stock Analysis - click HERE

Overnight Price: $4.79

Ord Minnett rates IGO as Upgrade to Lighten from Sell (4) -

Ord Minnett remains cautiously optimistic that recent board changes could translate to much-needed change.

The broker continues to question a Trop sale although acknowledges, with the review ongoing, IGO Ltd could still realise a reasonable return on the back of spot gold prices as well as re-rate if converted into a nickel mine.

Despite some "generous assumptions" the broker finds the valuation heavy going, upgrading to Lighten from Sell. Target is raised to $4.30 from $3.40.

Target price is $4.30 Current Price is $4.79 Difference: minus $0.49 (current price is over target).
If IGO meets the Ord Minnett target it will return approximately minus 10% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $4.88, suggesting upside of 0.4% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

Ord Minnett forecasts a full year FY21 dividend of 10.00 cents and EPS of 23.50 cents.
At the last closing share price the estimated dividend yield is 2.09%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.38.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 22.9, implying annual growth of -12.8%.

Current consensus DPS estimate is 11.8, implying a prospective dividend yield of 2.4%.

Current consensus EPS estimate suggests the PER is 21.2.

Forecast for FY22:

Ord Minnett forecasts a full year FY22 dividend of 10.00 cents and EPS of 16.70 cents.
At the last closing share price the estimated dividend yield is 2.09%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 28.68.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 24.8, implying annual growth of 8.3%.

Current consensus DPS estimate is 11.3, implying a prospective dividend yield of 2.3%.

Current consensus EPS estimate suggests the PER is 19.6.

Market Sentiment: 0.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

IPD  IMPEDIMED LIMITED

Medical Equipment & Devices

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.16

Morgans rates IPD as Add (1) -

ImpediMed announced the publication of a meta-analysis. This demonstrated that the use of L-Dex results in a clinically significant reduction of the chronic breast cancer related lymphoedema (BCRL) rate. This is by comparison with the current standard of care.

The broker believes external validation of the technology and the company’s own longitudinal studies is a catalyst to begin presenting to private payors. It’s also considered it may be a trigger for potential inclusion in national cancer care guidelines.

While making no changes to forecasts, Morgans notes significant upside remains in higher than forecast uptake in the lymphoedema and heart failure products. 

The Speculative Buy rating and $0.20 target price are unchanged.

Target price is $0.20 Current Price is $0.16 Difference: $0.04
If IPD meets the Morgans target it will return approximately 25% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 0.00 cents and EPS of minus 1.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 13.33.

Forecast for FY22:

Morgans forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 0.05 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 320.00.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

LOV  LOVISA HOLDINGS LIMITED

Luxury

More Research Tools In Stock Analysis - click HERE

Overnight Price: $10.50

Citi rates LOV as Neutral (3) -

Lovisa has announced the acquisition of 30 beeline stores in France as part of its existing agreement. This increases the estimated FY21 store count by 5%.

Given Lovisa already has 24 stores in France the additional stores should provide greater leverage in lease negotiations as well as brand awareness.

Nevertheless, Citi believes the company needs to navigate the reduced shopping centre traffic that is now a feature of the increasing shift towards online shopping.

Sales also need to be pushed along in the largest growth market, the US, where the coronavirus outbreak has had a resurgence.

As a result, the broker retains a Neutral rating and raises the target to $11.90 from $11.60.

Target price is $11.90 Current Price is $10.50 Difference: $1.4
If LOV meets the Citi target it will return approximately 13% (excluding dividends, fees and charges).

Current consensus price target is $12.27, suggesting upside of 10.1% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

Citi forecasts a full year FY21 dividend of 7.50 cents and EPS of 32.10 cents.
At the last closing share price the estimated dividend yield is 0.71%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 32.71.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 22.5, implying annual growth of 112.3%.

Current consensus DPS estimate is 9.6, implying a prospective dividend yield of 0.9%.

Current consensus EPS estimate suggests the PER is 49.5.

Forecast for FY22:

Citi forecasts a full year FY22 dividend of 12.50 cents and EPS of 49.80 cents.
At the last closing share price the estimated dividend yield is 1.19%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.08.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 38.1, implying annual growth of 69.3%.

Current consensus DPS estimate is 23.4, implying a prospective dividend yield of 2.1%.

Current consensus EPS estimate suggests the PER is 29.2.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

MCP  MCPHERSON'S LIMITED

Health & Nutrition

More Research Tools In Stock Analysis - click HERE

Overnight Price: $1.20

Ord Minnett rates MCP as Buy (1) -

McPherson's has issued a major revision to earnings following a slump in sales in Dr LeWinn's within the Access Brand Management distribution channel in China. Ord Minnett reduces FY21 pre-tax profit forecasts by -24%.

The broker suggests the magnitude of the contraction points to issues within the distribution channel and/or a lack of impact from recent Dr LeWinn's product launches.

Still, five out of the six core fully-owned brands are expected to trade positively during the first half, being well-established. Buy retained. Target is reduced to $1.79 from $3.00.

Target price is $1.79 Current Price is $1.20 Difference: $0.59
If MCP meets the Ord Minnett target it will return approximately 49% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY21:

Ord Minnett forecasts a full year FY21 dividend of 9.00 cents and EPS of 12.30 cents.
At the last closing share price the estimated dividend yield is 7.50%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.76.

Forecast for FY22:

Ord Minnett forecasts a full year FY22 dividend of 10.00 cents and EPS of 12.90 cents.
At the last closing share price the estimated dividend yield is 8.33%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.30.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

MVF  MONASH IVF GROUP LIMITED

Healthcare services

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.74

Morgans rates MVF as Add (1) -

At the AGM, Monash IVF noted a strong rebound from July to October. This was indicated by stimulated cycles growing by 23.1%, international up 16.2% and the Ultrasound business up 10.7%. 

Morgans upgrades FY21-23 EPS forecasts by 11.7%, 7.7% and 1.6%, respectively, after increasing cycle volume growth assumptions.

The broker also increases dividend assumptions to 4 cents from 3 cents for FY21, and then growing by 10% per annum.

The Add rating is unchanged and the target is increased to $0.85 from $0.65.

Target price is $0.85 Current Price is $0.74 Difference: $0.11
If MVF meets the Morgans target it will return approximately 15% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY21:

Morgans forecasts a full year FY21 dividend of 4.00 cents and EPS of 5.30 cents.
At the last closing share price the estimated dividend yield is 5.41%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.96.

Forecast for FY22:

Morgans forecasts a full year FY22 dividend of 4.40 cents and EPS of 5.50 cents.
At the last closing share price the estimated dividend yield is 5.95%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.45.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

ORA  ORORA LIMITED

Paper & Packaging

More Research Tools In Stock Analysis - click HERE

Overnight Price: $2.67

Credit Suisse rates ORA as Neutral (3) -

Credit Suisse reduces estimates on the basis that import tariffs on wine to China will remain in place beyond the interim measures that have been announced. This should be partially offset by improved momentum in Orora's North American packaging distribution.

The company supplies a little over 50% of the Australian wine bottle market and also has exposure through its wine closure business.

Credit Suisse notes the March 2020 vintage was low yield and affected wine production during FY21. A modest rebound is expected in March 2021 although the vintage may be hampered by lack of Chinese demand. Neutral retained. Target is $2.80.

Target price is $2.80 Current Price is $2.67 Difference: $0.13
If ORA meets the Credit Suisse target it will return approximately 5% (excluding dividends, fees and charges).

Current consensus price target is $2.76, suggesting upside of 4.2% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

Credit Suisse forecasts a full year FY21 dividend of 11.00 cents and EPS of 14.84 cents.
At the last closing share price the estimated dividend yield is 4.12%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.99.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 15.3, implying annual growth of 427.6%.

Current consensus DPS estimate is 11.4, implying a prospective dividend yield of 4.3%.

Current consensus EPS estimate suggests the PER is 17.3.

Forecast for FY22:

Credit Suisse forecasts a full year FY22 dividend of 11.80 cents and EPS of 16.45 cents.
At the last closing share price the estimated dividend yield is 4.42%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.23.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 17.2, implying annual growth of 12.4%.

Current consensus DPS estimate is 12.3, implying a prospective dividend yield of 4.6%.

Current consensus EPS estimate suggests the PER is 15.4.

Market Sentiment: 0.1

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

PLS  PILBARA MINERALS LIMITED

New Battery Elements

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.75

Macquarie rates PLS as Underperform (5) -

Pilbara Minerals executed a share sale agreement for acquiring the Altura Lithium operations from Altura Mining ((AJM)).

The lithium producer has also proposed to increase its contribution to the Deed of Company Arrangement (DOCA) to $6m from $4m on the basis that the second creditors meeting is held on or before 11 December 2020.

Due to research restrictions, Macquarie cannot advise its valuation on the company at present.

Current Price is $0.75. Target price not assessed.

Current consensus price target is $0.36, suggesting downside of -50.7% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 0.00 cents and EPS of minus 1.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 53.57.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -1.0, implying annual growth of N/A.

Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.

Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY22:

Macquarie forecasts a full year FY22 dividend of 0.00 cents and EPS of minus 1.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 57.69.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 0.5, implying annual growth of N/A.

Current consensus DPS estimate is 0.2, implying a prospective dividend yield of 0.3%.

Current consensus EPS estimate suggests the PER is 146.0.

Market Sentiment: -0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

QAN  QANTAS AIRWAYS LIMITED

Transportation & Logistics

More Research Tools In Stock Analysis - click HERE

Overnight Price: $5.47

UBS rates QAN as Buy (1) -

UBS assesses the opening of borders by the West Australian government with New South Wales and Victoria on December 8 will take the un-quarantined capacity to 95%, up from 40% two weeks ago. Qantas expects to be flying 60% of pre-covid capacity by Christmas.

The broker notes the airways has enough liquidity and is expected to be back to FY19 levels by FY23, driven by a rebound in working capital and a lack of growth capex.

UBS retains its Buy rating (under review) with a target price of $5.25.

Target price is $5.25 Current Price is $5.47 Difference: minus $0.22 (current price is over target).
If QAN meets the UBS target it will return approximately minus 4% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $4.45, suggesting downside of -19.8% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 0.00 cents and EPS of minus 33.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 16.58.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -39.3, implying annual growth of N/A.

Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.

Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY22:

UBS forecasts a full year FY22 dividend of 0.00 cents and EPS of 27.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.26.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 28.7, implying annual growth of N/A.

Current consensus DPS estimate is 1.8, implying a prospective dividend yield of 0.3%.

Current consensus EPS estimate suggests the PER is 19.3.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

SFR  SANDFIRE RESOURCES NL

Copper

More Research Tools In Stock Analysis - click HERE

Overnight Price: $4.81

Macquarie rates SFR as Upgrade to Outperform from Neutral (1) -

Sandfire Resources has approved the development of its T3 Motheo copper-silver project in Botswana, which is expected to deliver around 30ktpa of copper for 10 years.

After incorporating the expanded production scenario, Macquarie's FY21 earnings forecast rise by 1%. Earnings forecasts for FY25-28 rise by 7-28% and by 100% for FY29.

Rating is upgraded to Outperform from Neutral with the target rising to $5.40 from $4.20.

Target price is $5.40 Current Price is $4.81 Difference: $0.59
If SFR meets the Macquarie target it will return approximately 12% (excluding dividends, fees and charges).

Current consensus price target is $5.41, suggesting upside of 0.2% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 13.00 cents and EPS of 59.80 cents.
At the last closing share price the estimated dividend yield is 2.70%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.04.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 60.7, implying annual growth of 41.6%.

Current consensus DPS estimate is 17.4, implying a prospective dividend yield of 3.2%.

Current consensus EPS estimate suggests the PER is 8.9.

Forecast for FY22:

Macquarie forecasts a full year FY22 dividend of 2.00 cents and EPS of 6.30 cents.
At the last closing share price the estimated dividend yield is 0.42%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 76.35.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 55.4, implying annual growth of -8.7%.

Current consensus DPS estimate is 14.9, implying a prospective dividend yield of 2.8%.

Current consensus EPS estimate suggests the PER is 9.7.

Market Sentiment: 0.6

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Morgan Stanley rates SFR as Overweight (1) -

The company is progressing T3 in a somewhat better fashion than Morgan Stanley had expected. The A4 appears increasingly likely to have a life of around 3.25 years at an expanded throughput rate of 5.2mtpa.

Average annual production of around 30,000tpa is higher than Morgan Stanley expected but so are costs.

The A4 dome has a maiden resource of 6.5mt at 1.5% copper and 24g/t silver. The broker notes grades may change as material is upgraded to reserve.

Overweight maintained. Industry view: Attractive. Target is $6.60.

Target price is $6.60 Current Price is $4.81 Difference: $1.79
If SFR meets the Morgan Stanley target it will return approximately 37% (excluding dividends, fees and charges).

Current consensus price target is $5.41, suggesting upside of 0.2% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 dividend of 29.00 cents and EPS of 83.00 cents.
At the last closing share price the estimated dividend yield is 6.03%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 5.80.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 60.7, implying annual growth of 41.6%.

Current consensus DPS estimate is 17.4, implying a prospective dividend yield of 3.2%.

Current consensus EPS estimate suggests the PER is 8.9.

Forecast for FY22:

Morgan Stanley forecasts a full year FY22 dividend of 31.00 cents and EPS of 88.00 cents.
At the last closing share price the estimated dividend yield is 6.44%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 5.47.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 55.4, implying annual growth of -8.7%.

Current consensus DPS estimate is 14.9, implying a prospective dividend yield of 2.8%.

Current consensus EPS estimate suggests the PER is 9.7.

Market Sentiment: 0.6

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

SSR  SSR MINING INC

Gold & Silver

More Research Tools In Stock Analysis - click HERE

Overnight Price: $25.39

UBS rates SSR as Buy (1) -

SSR Mining's Copler technical report has the mine plan that pegs production of circa 300kozpa for the next 10 years at Copler and a mine life beyond 20 years.

While confirming Copler is a large scale and low-cost operation, the report's production outlook falls at the lower end of the vision targeted by management when it outlined a 300-400kozpa profile for the next 10 years. 

Nevertheless, UBS considers its forecasts are now better calibrated and carry lower risk.

Considering the company is at an inflection point with the company's major assets entering a cash harvest mode, UBS retains its Buy rating with the target trimmed to $32 from $33 target. 

Target price is $32.00 Current Price is $25.39 Difference: $6.61
If SSR meets the UBS target it will return approximately 26% (excluding dividends, fees and charges).

The company's fiscal year ends in December.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 67.00 cents and EPS of 226.00 cents.
At the last closing share price the estimated dividend yield is 2.64%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.23.

Forecast for FY22:

UBS forecasts a full year FY22 dividend of 89.00 cents and EPS of 179.00 cents.
At the last closing share price the estimated dividend yield is 3.51%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.18.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

STO  SANTOS LIMITED

NatGas

More Research Tools In Stock Analysis - click HERE

Overnight Price: $6.21

Citi rates STO as Buy (1) -

Citi believes Santos is the best positioned to execute on growth, with a consistent track record and a balance sheet that is supported by CPI-indexed production.

The broker also finds the commitment to Barossa a positive and the further details provided in the market briefing should put to rest any fears.

Citi retains a Buy rating and raises the target to $7.34 from $6.76.

Target price is $7.34 Current Price is $6.21 Difference: $1.13
If STO meets the Citi target it will return approximately 18% (excluding dividends, fees and charges).

Current consensus price target is $6.67, suggesting upside of 6.7% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

Citi forecasts a full year FY20 dividend of 7.15 cents and EPS of 19.85 cents.
At the last closing share price the estimated dividend yield is 1.15%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 31.28.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 28.2, implying annual growth of N/A.

Current consensus DPS estimate is 6.3, implying a prospective dividend yield of 1.0%.

Current consensus EPS estimate suggests the PER is 22.2.

Forecast for FY21:

Citi forecasts a full year FY21 dividend of 8.17 cents and EPS of 37.37 cents.
At the last closing share price the estimated dividend yield is 1.32%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.62.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 34.7, implying annual growth of 23.0%.

Current consensus DPS estimate is 8.0, implying a prospective dividend yield of 1.3%.

Current consensus EPS estimate suggests the PER is 18.0.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.7

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Credit Suisse rates STO as Downgrade to Neutral from Outperform (3) -

The company provided positive production and operating expenditure guidance at its investor briefing. New investments have experienced strong 20-60% margins. The company's 26-30% carbon emission reduction target by 2030 appears plausible to the broker.

While the view on fundamentals has not changed and Santos remains the preferred pick for oil, having a number of catalysts over the next 18 months, the equity has rallied ahead of industry sentiment.

Hence, Credit Suisse would need to witness price assumptions increase beyond the macro view to justify further upside. Rating is downgraded to Neutral from Outperform and the target is raised to $6.40 from $6.33.

Target price is $6.40 Current Price is $6.21 Difference: $0.19
If STO meets the Credit Suisse target it will return approximately 3% (excluding dividends, fees and charges).

Current consensus price target is $6.67, suggesting upside of 6.7% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

Credit Suisse forecasts a full year FY20 dividend of 4.89 cents and EPS of 26.97 cents.
At the last closing share price the estimated dividend yield is 0.79%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.02.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 28.2, implying annual growth of N/A.

Current consensus DPS estimate is 6.3, implying a prospective dividend yield of 1.0%.

Current consensus EPS estimate suggests the PER is 22.2.

Forecast for FY21:

Credit Suisse forecasts a full year FY21 dividend of 8.64 cents and EPS of 38.62 cents.
At the last closing share price the estimated dividend yield is 1.39%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.08.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 34.7, implying annual growth of 23.0%.

Current consensus DPS estimate is 8.0, implying a prospective dividend yield of 1.3%.

Current consensus EPS estimate suggests the PER is 18.0.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.7

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Macquarie rates STO as Neutral (3) -

With free cash flow more than US$650m in 2020, Macquarie notes Santos's base business did well during the pandemic.

Also, the company's midstream business has been legally separated with management targeting a further -30% reduction in processing costs.

Given relative sector movements, Macquarie considers Santos to be relatively more appealing than Oil Search ((OSH)). 

Macquarie holds onto its Neutral rating with the target price rising to $6.25 from $5.40. 

Target price is $6.25 Current Price is $6.21 Difference: $0.04
If STO meets the Macquarie target it will return approximately 1% (excluding dividends, fees and charges).

Current consensus price target is $6.67, suggesting upside of 6.7% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

Macquarie forecasts a full year FY20 dividend of 6.90 cents and EPS of 17.00 cents.
At the last closing share price the estimated dividend yield is 1.11%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 36.53.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 28.2, implying annual growth of N/A.

Current consensus DPS estimate is 6.3, implying a prospective dividend yield of 1.0%.

Current consensus EPS estimate suggests the PER is 22.2.

Forecast for FY21:

Macquarie forecasts a full year FY21 dividend of 7.00 cents and EPS of 23.80 cents.
At the last closing share price the estimated dividend yield is 1.13%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 26.09.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 34.7, implying annual growth of 23.0%.

Current consensus DPS estimate is 8.0, implying a prospective dividend yield of 1.3%.

Current consensus EPS estimate suggests the PER is 18.0.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.7

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Morgan Stanley rates STO as Overweight (1) -

Morgan Stanley assesses Santos continues to have a range of realistic growth opportunities for the short term. 2020 production guidance has been upgraded to 87-89 mmboe while costs guidance has been lowered to US$8-8.5/boe.

Synergies for the ConocoPhillips acquisition were raised to US$90-105m. FID on Barossa is delayed by six months, which the broker suspects is a best case scenario although LNG prices are rising.

The broker concludes that execution on growth plans is pivotal for the future valuation of the stock at appropriate commodity prices. Overweight retained. Target is $6.30. Industry view: Cautious.

Target price is $6.30 Current Price is $6.21 Difference: $0.09
If STO meets the Morgan Stanley target it will return approximately 1% (excluding dividends, fees and charges).

Current consensus price target is $6.67, suggesting upside of 6.7% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

Morgan Stanley forecasts a full year FY20 dividend of 6.13 cents and EPS of 18.98 cents.
At the last closing share price the estimated dividend yield is 0.99%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 32.73.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 28.2, implying annual growth of N/A.

Current consensus DPS estimate is 6.3, implying a prospective dividend yield of 1.0%.

Current consensus EPS estimate suggests the PER is 22.2.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 dividend of 10.80 cents and EPS of 29.19 cents.
At the last closing share price the estimated dividend yield is 1.74%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.27.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 34.7, implying annual growth of 23.0%.

Current consensus DPS estimate is 8.0, implying a prospective dividend yield of 1.3%.

Current consensus EPS estimate suggests the PER is 18.0.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.7

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


UPDATED

Ord Minnett rates STO as Buy (1) -

Ord Minnett found the investor briefing upbeat, as management outlined the potential value creation from infrastructure.

Ongoing capital costs for the base business are substantially higher than the broker has estimated, with sustaining capital likely to be US$900m annually.

Incorporating this, the target price is lowered to $6.80 from $7.35. Ord Minnett retains a Buy rating and the stock is its preferred pick in the sector.

This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.

Target price is $6.80 Current Price is $6.21 Difference: $0.59
If STO meets the Ord Minnett target it will return approximately 10% (excluding dividends, fees and charges).

Current consensus price target is $6.67, suggesting upside of 6.7% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

Ord Minnett forecasts a full year FY20 dividend of 11.68 cents and EPS of 18.98 cents.
At the last closing share price the estimated dividend yield is 1.88%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 32.73.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 28.2, implying annual growth of N/A.

Current consensus DPS estimate is 6.3, implying a prospective dividend yield of 1.0%.

Current consensus EPS estimate suggests the PER is 22.2.

Forecast for FY21:

Ord Minnett forecasts a full year FY21 dividend of 10.22 cents and EPS of 33.57 cents.
At the last closing share price the estimated dividend yield is 1.65%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.50.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 34.7, implying annual growth of 23.0%.

Current consensus DPS estimate is 8.0, implying a prospective dividend yield of 1.3%.

Current consensus EPS estimate suggests the PER is 18.0.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.7

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


UBS rates STO as Buy (1) -

UBS has increased its base business valuation to $4.84 per share which helps offset delays to its growth projects.

Final investment decision for Santos' growth projects is now staggered over three years with decision on Barossa and Moomba CCS expected in 2021 while decisions on Dorado and Narrabri are expected by 2022-23.

With challenging market conditions, Santos stated it won't make a decision on Barossa without at least some of its 1.5-1.8mtpa equity share of Barossa gas contracted.

Target is $6.60. Buy retained.

Target price is $6.60 Current Price is $6.21 Difference: $0.39
If STO meets the UBS target it will return approximately 6% (excluding dividends, fees and charges).

Current consensus price target is $6.67, suggesting upside of 6.7% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

UBS forecasts a full year FY20 dividend of 5.84 cents and EPS of 26.27 cents.
At the last closing share price the estimated dividend yield is 0.94%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.64.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 28.2, implying annual growth of N/A.

Current consensus DPS estimate is 6.3, implying a prospective dividend yield of 1.0%.

Current consensus EPS estimate suggests the PER is 22.2.

Forecast for FY21:

UBS forecasts a full year FY21 dividend of 7.30 cents and EPS of 43.79 cents.
At the last closing share price the estimated dividend yield is 1.18%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.18.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 34.7, implying annual growth of 23.0%.

Current consensus DPS estimate is 8.0, implying a prospective dividend yield of 1.3%.

Current consensus EPS estimate suggests the PER is 18.0.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.7

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

SYR  SYRAH RESOURCES LIMITED

New Battery Elements

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.95

Morgan Stanley rates SYR as Equal-weight (3) -

Syrah Resources has the bankable feasibility study for active anode material at Vidalia. The plan is to continue with FEED for the initial 10,000tpa facility, intended for completion in the first quarter of 2021.

Morgan Stanley notes the cash balance is US$44m, significantly below the capital expenditure required for this plant.

The broker calculates, even if Balama were to produce an economic run rate of 15,000t per month the graphite price would need to be US$1000/t - compared with the current US$400-500/t - in order for the cash to be ready before construction starts.

Equal-weight. Target is $0.45. Industry view: Attractive.

Target price is $0.45 Current Price is $0.95 Difference: minus $0.5 (current price is over target).
If SYR meets the Morgan Stanley target it will return approximately minus 53% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $0.77, suggesting downside of -27.0% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY20:

Morgan Stanley forecasts a full year FY20 dividend of 0.00 cents and EPS of minus 11.68 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 8.14.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -12.9, implying annual growth of N/A.

Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.

Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY21:

Morgan Stanley forecasts a full year FY21 dividend of 0.00 cents and EPS of minus 7.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 13.02.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -8.6, implying annual growth of N/A.

Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.

Current consensus EPS estimate suggests the PER is N/A.

This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: 0.7

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

VVA  VIVA LEISURE LIMITED

Travel, Leisure & Tourism

More Research Tools In Stock Analysis - click HERE

Overnight Price: $3.25

Ord Minnett rates VVA as Buy (1) -

Viva Leisure has secured an increased debt facility and the equity required to grow to 400 clubs by FY25. Ord Minnett assesses acquisitions and buybacks offer more meaningful opportunities for deploying capital at returns on investment of up to 30%.

The broker observes the pandemic has provided a number of willing sellers at cheap multiples.

Near-term forecasts are reduced because of the dilution of the capital raising while long-term estimates are raised by around 10% to account for an increased club network. Buy retained. Target is raised to $4.60 from $4.25.

Target price is $4.60 Current Price is $3.25 Difference: $1.35
If VVA meets the Ord Minnett target it will return approximately 42% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY21:

Ord Minnett forecasts a full year FY21 dividend of 0.00 cents and EPS of 9.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 33.85.

Forecast for FY22:

Ord Minnett forecasts a full year FY22 dividend of 0.00 cents and EPS of 18.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.47.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

WBC  WESTPAC BANKING CORPORATION

Banks

More Research Tools In Stock Analysis - click HERE

Overnight Price: $20.28

Ord Minnett rates WBC as Hold (3) -

Westpac Banking Corp has announced two developments including an enforceable undertaking over risk governance remediation and measures related to an historical breach of liquidity requirements involving the New Zealand subsidiary.

Ord Minnett suggests these further measures are a sign that remediation has not gone far enough or has not achieved a desired outcome in a timely fashion.

The broker considers execution risk is elevated, given the significant churn in senior management recently. Hold rating retained. Target is $20.20.

This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.

Target price is $20.20 Current Price is $20.28 Difference: minus $0.08 (current price is over target).
If WBC meets the Ord Minnett target it will return approximately minus 0% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $21.17, suggesting upside of 4.3% (ex-dividends)

The company's fiscal year ends in September.

Forecast for FY21:

Ord Minnett forecasts a full year FY21 dividend of 90.00 cents and EPS of 136.00 cents.
At the last closing share price the estimated dividend yield is 4.44%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.91.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 147.7, implying annual growth of 103.7%.

Current consensus DPS estimate is 85.6, implying a prospective dividend yield of 4.2%.

Current consensus EPS estimate suggests the PER is 13.7.

Forecast for FY22:

Ord Minnett forecasts a full year FY22 dividend of 110.00 cents and EPS of 154.00 cents.
At the last closing share price the estimated dividend yield is 5.42%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.17.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 158.3, implying annual growth of 7.2%.

Current consensus DPS estimate is 112.0, implying a prospective dividend yield of 5.5%.

Current consensus EPS estimate suggests the PER is 12.8.

Market Sentiment: 0.9

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

WEB  WEBJET LIMITED

Travel, Leisure & Tourism

More Research Tools In Stock Analysis - click HERE

Overnight Price: $5.79

Ord Minnett rates WEB as Downgrade to Hold from Buy (3) -

Ord Minnett finds valuation stretched in the travel & tourism sector as stocks have rallied on the back of progress with the coronavirus vaccines and domestic border re-opening.

Nevertheless, the broker suspects a meaningful recovery is at least 12-18 months away.

In such circumstances the focus needs to be on stocks that have strong fundamentals while investors need to be nimble and watch for anomalies in valuation at any point in time, in Ord Minnett's view.

The broker downgrades Webjet to Hold from Buy and the target is raised to $5.52 from $4.58.

Target price is $5.52 Current Price is $5.79 Difference: minus $0.27 (current price is over target).
If WEB meets the Ord Minnett target it will return approximately minus 5% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $4.17, suggesting downside of -27.5% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY21:

Ord Minnett forecasts a full year FY21 dividend of 0.00 cents and EPS of minus 23.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 24.74.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is -13.1, implying annual growth of N/A.

Current consensus DPS estimate is -0.3, implying a prospective dividend yield of -0.1%.

Current consensus EPS estimate suggests the PER is N/A.

Forecast for FY22:

Ord Minnett forecasts a full year FY22 dividend of 0.60 cents and EPS of 10.90 cents.
At the last closing share price the estimated dividend yield is 0.10%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 53.12.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 13.5, implying annual growth of N/A.

Current consensus DPS estimate is 2.4, implying a prospective dividend yield of 0.4%.

Current consensus EPS estimate suggests the PER is 42.6.

Market Sentiment: 0.2

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Today's Price Target Changes
Company Last Price Broker New Target Prev Target Change
AUB AUB Group $17.08 Macquarie 18.57 17.53 5.93%
CKF Collins Foods $10.36 Morgans 11.39 10.80 5.46%
UBS 11.65 10.65 9.39%
CSL CSL $296.71 Macquarie 296.00 295.00 0.34%
CTD Corporate Travel $19.58 Ord Minnett 21.93 19.04 15.18%
DMP Domino's Pizza $82.08 Morgans 82.96 81.29 2.05%
EVN Evolution Mining $5.20 Ord Minnett 4.20 4.50 -6.67%
FLT Flight Centre $17.26 Ord Minnett 15.35 9.70 58.25%
GNC Graincorp $4.55 Macquarie 5.35 5.26 1.71%
UBS 5.15 4.90 5.10%
GOR Gold Road Resources $1.29 Ord Minnett 2.10 2.20 -4.55%
HLO HELLOWORLD TRAVEL $2.85 Ord Minnett 2.65 2.13 24.41%
IFL IOOF Holdings $3.82 Citi N/A 4.70 -100.00%
IGO IGO Co $4.86 Ord Minnett 4.30 3.40 26.47%
Ord Minnett 4.30 3.40 26.47%
LOV Lovisa Holdings $11.14 Citi 11.90 11.60 2.59%
MCP Mcpherson'S $1.25 Ord Minnett 1.79 3.00 -40.33%
MVF Monash IVF $0.73 Morgans 0.85 0.65 30.77%
NCM Newcrest Mining $27.82 Ord Minnett 34.10 34.90 -2.29%
NST Northern Star $13.04 Ord Minnett 13.20 14.00 -5.71%
OGC Oceanagold $1.89 Ord Minnett 3.15 3.35 -5.97%
RRL Regis Resources $3.92 Ord Minnett 4.10 4.50 -8.89%
SAR Saracen Mineral $4.89 Ord Minnett 5.00 5.30 -5.66%
SBM St Barbara $2.61 Ord Minnett 3.10 3.50 -11.43%
SFR Sandfire $5.40 Macquarie 5.40 4.20 28.57%
SSR SSR MINING $26.50 UBS 32.00 33.00 -3.03%
STO Santos $6.25 Citi 7.34 6.76 8.58%
Credit Suisse 6.40 6.63 -3.47%
Macquarie 6.25 5.40 15.74%
Morgan Stanley 6.30 6.20 1.61%
Ord Minnett 6.80 7.30 -6.85%
VVA Viva Leisure $3.26 Ord Minnett 4.60 4.25 8.24%
WEB Webjet $5.75 Ord Minnett 5.52 4.58 20.52%
Summaries
ABY ADORE BEAUTY GROUP Overweight - Morgan Stanley Overnight Price $6.33
AUB AUB Group Outperform - Macquarie Overnight Price $16.67
CKF Collins Foods Add - Morgans Overnight Price $10.37
Buy - UBS Overnight Price $10.37
CSL CSL Neutral - Macquarie Overnight Price $299.75
Equal-weight - Morgan Stanley Overnight Price $299.75
DMP Domino's Pizza Upgrade to Add from Hold - Morgans Overnight Price $83.17
Upgrade to Neutral from Sell - UBS Overnight Price $83.17
FBU Fletcher Building Neutral - UBS Overnight Price $5.48
GNC Graincorp Outperform - Macquarie Overnight Price $4.45
Buy - UBS Overnight Price $4.45
GPT GPT Group Neutral - Macquarie Overnight Price $4.67
Underweight - Morgan Stanley Overnight Price $4.67
HLO HELLOWORLD TRAVEL Downgrade to Lighten from Buy - Ord Minnett Overnight Price $3.00
IFL IOOF Holdings No Rating - Citi Overnight Price $3.88
Outperform - Credit Suisse Overnight Price $3.88
Buy - Ord Minnett Overnight Price $3.88
IGO IGO Co Upgrade to Lighten from Sell - Ord Minnett Overnight Price $4.79
IPD Impedimed Add - Morgans Overnight Price $0.16
LOV Lovisa Holdings Neutral - Citi Overnight Price $10.50
MCP Mcpherson'S Buy - Ord Minnett Overnight Price $1.20
MVF Monash IVF Add - Morgans Overnight Price $0.74
ORA Orora Neutral - Credit Suisse Overnight Price $2.67
PLS Pilbara Minerals Underperform - Macquarie Overnight Price $0.75
QAN Qantas Airways Buy - UBS Overnight Price $5.47
SFR Sandfire Upgrade to Outperform from Neutral - Macquarie Overnight Price $4.81
Overweight - Morgan Stanley Overnight Price $4.81
SSR SSR MINING Buy - UBS Overnight Price $25.39
STO Santos Buy - Citi Overnight Price $6.21
Downgrade to Neutral from Outperform - Credit Suisse Overnight Price $6.21
Neutral - Macquarie Overnight Price $6.21
Overweight - Morgan Stanley Overnight Price $6.21
Buy - Ord Minnett Overnight Price $6.21
Buy - UBS Overnight Price $6.21
SYR Syrah Resources Equal-weight - Morgan Stanley Overnight Price $0.95
VVA Viva Leisure Buy - Ord Minnett Overnight Price $3.25
WBC Westpac Banking Hold - Ord Minnett Overnight Price $20.28
WEB Webjet Downgrade to Hold from Buy - Ord Minnett Overnight Price $5.79
RATING SUMMARY
Rating No. Of Recommendations
1. Buy

21

3. Hold

12

4. Reduce

2

5. Sell

2

Wednesday 02 December 2020

Access Broker Call Report Archives here

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface. This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.